Chicago Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $101M | Sell |
|
|||||
|
2025
Q2 | $65M | Buy |
|
|||||
|
2025
Q1 | $58.3M | Buy |
|
|||||
|
2024
Q4 | $59.1M | Buy |
|
|||||
|
2024
Q3 | $54.6M | Buy |
|
|||||
|
2024
Q2 | $43.4M | Buy |
|
|||||
|
2024
Q1 | $16.8M | Sell |
|
|||||
|
2023
Q4 | $16.5M | Sell |
|
|||||
|
2023
Q3 | $21.6M | Sell |
|
|||||
|
2023
Q2 | $30.6M | Sell |
|
|||||
|
2023
Q1 | $33.1M | Buy |
|
|||||
|
2022
Q4 | $21.3M | Sell |
|
|||||
|
2022
Q3 | $39.6M | Buy |
|
|||||
|
2022
Q2 | $40M | Sell |
|
|||||
|
2022
Q1 | $55.3M | Buy |
|
|||||
|
2021
Q4 | $67.4M | Sell |
|
|||||
|
2021
Q3 | $61.3M | Sell |
|
|||||
|
2021
Q2 | $60.2M | Buy |
|
|||||
|
2021
Q1 | $68.4M | Buy |
|
|||||
|
2020
Q4 | $33.1M | Sell |
|
|||||
|
2020
Q3 | $46.3M | Buy |
|
|||||
|
2020
Q2 | $30.1M | Buy |
|